Editas Medicine
EDIT
EDIT
225 hedge funds and large institutions have $609M invested in Editas Medicine in 2023 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 74 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.21% less ownership
Funds ownership: 74.77% → 73.56% (-1.2%)
28% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 74
Holders
225
Holding in Top 10
–
Calls
$13.5M
Puts
$9.68M
Top Buyers
| 1 | +$12.1M | |
| 2 | +$6.99M | |
| 3 | +$5.85M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$5.63M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$5.42M |
Top Sellers
| 1 | -$24M | |
| 2 | -$16.5M | |
| 3 | -$11M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.11M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.38M |